Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Earnings
MedTech
Flying solo, Grail to cut 30% of staff, narrow cancer test focus
On its inaugural earnings call, Grail said it would focus solely on obtaining regulatory and reimbursement green lights for its Galleri blood test.
Conor Hale
Aug 14, 2024 11:30am
Lilly faces phase 2 failure of tau-targeting med
Aug 8, 2024 10:48am
Charles River reports Q2 dip in revenue and demand
Aug 7, 2024 3:10pm
Stoke's Dravet syndrome med released of partial clinical hold
Aug 7, 2024 8:54am
BD plans to surf GLP-1 wave to a $1B drug delivery biz by 2030
Aug 1, 2024 11:30am
Biogen CEO said no risky deals in 2023. Now he’s ready to be bold
Aug 1, 2024 10:34am
